Active Ingredient History
Pembrolizumab, sold under the brand name Keytruda, is a humanized antibody used in cancer immunotherapy that treats melanoma, lung cancer, head and neck cancer, Hodgkin lymphoma, stomach cancer, cervical cancer, and certain types of breast cancer. It is administered by slow intravenous injection. Wikipedia
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Abdominal Neoplasms (Phase 1/Phase 2)
Acquired Immunodeficiency Syndrome (Phase 2)
Acute Kidney Injury (Phase 2)
Adenocarcinoma (Phase 3)
Adenocarcinoma of Lung (Phase 3)
Adrenal Gland Neoplasms (Phase 2)
Adrenocortical Carcinoma (Phase 2)
Allergy and Immunology (Phase 2)
Androgens (Phase 2)
Anemia (Phase 1)
Anthracyclines (Phase 2)
Antigens, CD19 (Phase 1/Phase 2)
Anus Neoplasms (Phase 3)
Astrocytoma (Phase 1/Phase 2)
Bile Duct Neoplasms (Phase 2)
Biliary Tract Neoplasms (Phase 3)
Biomarkers (Phase 2)
Body Weight (Phase 2)
Bone Marrow Failure Disorders (Phase 2)
Bone Neoplasms (Phase 1)
Brain Neoplasms (Phase 3)
BRCA1 Protein (Phase 2)
Breast Diseases (Phase 2)
Breast Neoplasms (Phase 3)
Breast Neoplasms, Male (Phase 2)
Bronchial Diseases (Phase 3)
Bronchial Neoplasms (Phase 1)
Burkitt Lymphoma (Phase 1/Phase 2)
Carcinoid Tumor (Phase 2)
Carcinoma (Phase 3)
Carcinoma, Adenoid Cystic (Phase 2)
Carcinoma, Basal Cell (Phase 2)
Carcinoma, Bronchogenic (Phase 3)
Carcinoma, Hepatocellular (Phase 3)
Carcinoma in Situ (Phase 1)
Carcinoma, Intraductal, Noninfiltrating (Early Phase 1)
Carcinoma, Merkel Cell (Phase 3)
Carcinoma, Mucoepidermoid (Phase 2)
Carcinoma, Neuroendocrine (Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 4)
Carcinoma, Ovarian Epithelial (Phase 3)
Carcinoma, Renal Cell (Phase 3)
Carcinoma, Small Cell (Phase 2)
Carcinoma, Squamous Cell (Phase 3)
Carcinoma, Transitional Cell (Phase 3)
Carcinoma, Verrucous (Phase 2)
Castration (Phase 2)
Cells (Phase 2)
Central Nervous System Diseases (Phase 1/Phase 2)
Central Nervous System Neoplasms (Phase 2)
Cervical Intraepithelial Neoplasia (Phase 2)
Chest Wall Oscillation (Phase 2)
Cholangiocarcinoma (Phase 3)
Chondrosarcoma (Phase 1)
Colitis, Ulcerative (Phase 1/Phase 2)
Colonic Diseases (Phase 1/Phase 2)
Colonic Neoplasms (Phase 2)
Colorectal Neoplasms (Phase 3)
COVID-19 (Phase 2)
Cryotherapy (Phase 3)
Dendritic Cells (Phase 2)
Dendritic Cell Sarcoma, Follicular (Phase 2)
Dendritic Cell Sarcoma, Interdigitating (Phase 2)
Dermatology (Phase 1/Phase 2)
Diffuse Intrinsic Pontine Glioma (Phase 1)
Digestive System Neoplasms (Phase 2)
Disease Progression (Phase 2)
DNA Mismatch Repair (Phase 2)
DNA Repair-Deficiency Disorders (Phase 1)
Drugs, Investigational (Phase 3)
Drug Therapy (Phase 2)
Edema (Phase 2)
Endocrine Gland Neoplasms (Phase 1)
Endometrial Neoplasms (Phase 3)
Endoscopy (Phase 2)
Ependymoma (Phase 1)
Epidermal Growth Factor (Phase 1)
Epithelial Cells (Phase 2)
Epstein-Barr Virus Infections (Phase 2)
Erythema (Phase 2)
Esophageal Neoplasms (Phase 3)
Esophageal Squamous Cell Carcinoma (Phase 3)
Fallopian Tube Neoplasms (Phase 3)
Fever (Phase 2)
Fibrosarcoma (Phase 2)
Gallbladder Neoplasms (Phase 2)
Gastrointestinal Microbiome (Phase 1/Phase 2)
Gastrointestinal Stromal Tumors (Phase 2)
Genes, erbB-2 (Phase 1)
Genital Neoplasms, Female (Phase 2)
Genital Neoplasms, Male (Phase 2)
Gestational Trophoblastic Disease (Phase 2)
Glioblastoma (Phase 4)
Glioma (Phase 2)
Gliosarcoma (Phase 2)
Hamartoma (Phase 3)
Head and Neck Neoplasms (Phase 3)
Healthy Volunteers (Phase 1)
Hemangiopericytoma (Phase 2)
Hemangiosarcoma (Phase 2)
Hematologic Neoplasms (Phase 3)
Hepatitis C, Chronic (Phase 1/Phase 2)
Histiocytic Sarcoma (Phase 2)
HIV (Phase 1)
HIV Infections (Phase 1)
Hodgkin Disease (Phase 3)
Homologous Recombination (Phase 2)
Hypersensitivity (Phase 1)
Hypopharyngeal Neoplasms (Phase 3)
Immune Checkpoint Inhibitors (Phase 2)
Immune System Diseases (Phase 2)
Immunotherapy (Phase 2)
Infections (Phase 2)
Inflammatory Breast Neoplasms (Phase 2)
Infusions, Intravenous (Phase 4)
Intestinal Neoplasms (Phase 2)
Kidney Neoplasms (Phase 3)
Killer Cells, Natural (Phase 2)
Laryngeal Neoplasms (Phase 3)
Laryngectomy (Phase 2)
Leiomyosarcoma (Phase 2)
Leukemia, B-Cell (Phase 1)
Leukemia, Hairy Cell (Phase 1/Phase 2)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)
Leukemia, Myeloid, Acute (Phase 2)
Leukemia, Myeloid, Chronic-Phase (Phase 1)
Leukemia, Myelomonocytic, Chronic (Phase 1)
Leukoplakia (Phase 2)
Lip (Phase 2)
Liposarcoma (Phase 2)
Liver Neoplasms (Phase 2)
Lung Diseases (Phase 3)
Lung Neoplasms (Phase 3)
Lymph Nodes (Phase 2)
Lymphoma (Phase 2)
Lymphoma, B-Cell (Phase 2)
Lymphoma, B-Cell, Marginal Zone (Phase 2)
Lymphoma, Extranodal NK-T-Cell (Phase 2)
Lymphoma, Follicular (Phase 2)
Lymphoma, Large B-Cell, Diffuse (Phase 2)
Lymphoma, Large-Cell, Anaplastic (Phase 1/Phase 2)
Lymphoma, Large-Cell, Immunoblastic (Phase 2)
Lymphoma, Mantle-Cell (Phase 1/Phase 2)
Lymphoma, Non-Hodgkin (Phase 2)
Lymphoma, T-Cell (Phase 2)
Lymphoma, T-Cell, Cutaneous (Phase 2)
Lymphoma, T-Cell, Peripheral (Phase 2)
Mediastinal Neoplasms (Phase 2)
Medulloblastoma (Phase 1)
Melanoma ()
Meninges (Phase 2)
Meningioma (Phase 2)
Mesothelioma (Phase 3)
Mesothelioma, Malignant (Phase 2)
Microsatellite Instability (Phase 2)
Mouth Neoplasms (Phase 3)
Multiple Myeloma (Phase 3)
Mutation (Phase 2)
Mycosis Fungoides (Phase 2)
Myelodysplastic Syndromes (Phase 2)
Myeloproliferative Disorders (Phase 1/Phase 2)
Nasal Cavity (Phase 2)
Nasopharyngeal Carcinoma (Phase 2)
Nasopharyngeal Neoplasms (Phase 2)
Neoadjuvant Therapy (Phase 3)
Neoplasm Metastasis (Phase 3)
Neoplasm, Residual (Phase 2)
Neoplasms ()
Neoplasms, Adnexal and Skin Appendage (Phase 1)
Neoplasms by Histologic Type (Phase 3)
Neoplasms by Site (Phase 3)
Neoplasms, Experimental (Phase 1)
Neoplasms, Germ Cell and Embryonal (Phase 3)
Neoplasms, Glandular and Epithelial (Phase 2)
Neoplasms, Nerve Tissue (Phase 3)
Neoplasms, Neuroepithelial (Phase 2)
Neoplasms, Squamous Cell (Phase 2)
Nerve Sheath Neoplasms (Phase 2)
Nervous System Diseases (Phase 2)
Neuroblastoma (Phase 1)
Neuroectodermal Tumors (Phase 2)
Neuroendocrine Tumors (Phase 2)
Neurofibrosarcoma (Phase 1/Phase 2)
Oncogene Proteins (Phase 2)
Oncogenes (Phase 2)
Oropharyngeal Neoplasms (Phase 3)
Osteosarcoma (Phase 2)
Ovarian Diseases (Phase 2)
Ovarian Neoplasms (Phase 3)
Paget Disease, Extramammary (Phase 1)
Pancreatic Neoplasms (Phase 4)
Papilloma (Phase 1/Phase 2)
Papillomaviridae (Phase 2)
Papillomavirus Infections (Phase 1)
Paranasal Sinuses (Phase 2)
Pediatrics (Phase 1/Phase 2)
Pelvic Neoplasms (Phase 1/Phase 2)
Penile Neoplasms (Phase 2)
Peritoneal Neoplasms (Phase 3)
Pharmacokinetics (Phase 2)
Pheochromocytoma (Phase 2)
Pneumonia, Viral (Phase 2)
Polycythemia Vera (Phase 2)
Primary Myelofibrosis (Phase 2)
Prostatic Neoplasms (Phase 3)
Proto-Oncogene Proteins B-raf (Phase 2)
Radiosurgery (Phase 1/Phase 2)
Radiotherapy (Phase 2)
Rectal Neoplasms (Phase 2)
Recurrence (Phase 1/Phase 2)
Respiratory Tract Diseases (Phase 3)
Respiratory Tract Neoplasms (Phase 3)
Rhabdomyosarcoma (Phase 1)
Risk Factors (Phase 2)
Salivary Gland Neoplasms (Phase 2)
Sarcoma (Phase 2)
Sarcoma, Alveolar Soft Part (Phase 2)
Sarcoma, Clear Cell (Phase 2)
Sarcoma, Ewing (Phase 2)
Sarcoma, Kaposi (Phase 2)
Sarcoma, Synovial (Phase 2)
Sclerosis (Phase 2)
Sezary Syndrome (Phase 2)
Skin Diseases (Phase 2)
Skin Neoplasms (Phase 2)
Small Cell Lung Carcinoma (Phase 3)
Squamous Cell Carcinoma of Head and Neck (Phase 4)
Stomach Neoplasms (Phase 3)
Testicular Neoplasms (Phase 2)
Thoracic Neoplasms (Phase 3)
Thymoma (Phase 4)
Thymus Neoplasms (Phase 2)
Thyroid Carcinoma, Anaplastic (Phase 2)
Thyroid Gland (Phase 2)
Thyroid Neoplasms (Phase 2)
Tissues (Phase 1)
Triple Negative Breast Neoplasms (Phase 3)
Ureteral Neoplasms (Phase 3)
Urethral Neoplasms (Phase 2)
Urinary Bladder Neoplasms (Phase 3)
Urogenital Neoplasms (Phase 2)
Urologic Neoplasms (Phase 2)
Uterine Cervical Neoplasms (Phase 3)
Uterine Neoplasms (Phase 2)
Vaginal Diseases (Phase 2)
Vaginal Neoplasms (Phase 1/Phase 2)
Vascular Neoplasms (Phase 2)
Vulvar Diseases (Phase 1)
Vulvar Neoplasms (Phase 2)
Waldenstrom Macroglobulinemia (Phase 2)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
